Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Phase II Study of MEK Inhibitor Trametinib Alone and in Combination with AKT Inhibitor GSK2141795/uprosertib in Patients with Metastatic Triple Negative Breast Cancer

Vishnu Prasath,Hinda Boutrid,Robert Wesolowski,Mahmoud Abdel-Rasoul,Cynthia Timmers,Maryam Lustberg,Rachel M. Layman,Erin Macrae,Ewa Mrozek,Charles Shapiro, Kristyn Glover,Mark Vater,G. Thomas Budd,Lyndsay Harris,Claudine Isaacs,Claire Dees,Charles M. Perou,Gary L. Johnson,Andrew Poklepovic,Helen Chen,Miguel Villalona-Calero,William Carson,Daniel G. Stover,Bhuvaneswari Ramaswamy

Breast cancer research and treatment（2024）

Cited 0|Views0
Key words
Triple negative breast cancer,Tyrosine kinase inhibitors,MEK inhibition
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined